CEFTRIAXONE INJECTION IP

CEFTRIAXONE INJECTION IP is a powerful, broad-spectrum antibiotic formulation designed to combat a wide range of serious bacterial infections. As a third-generation cephalosporin, it offers exceptional efficacy against Gram-negative organisms, including *Escherichia coli*, *Klebsiella*, *Pseudomonas aeruginosa*, and *Haemophilus influenzae*. Administered intravenously, CEFTRIAXONE INJECTION IP provides rapid therapeutic action, making it a vital choice in hospital and critical care settings. Its high stability, reliable bioavailability, and well-established safety profile ensure consistent clinical performance. With its proven track record in treating severe infections such as sepsis, pneumonia, and complicated urinary tract infections, CEFTRIAXONE INJECTION IP stands as a cornerstone in modern antimicrobial therapy.